Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
EPA CPDat observed this chemical in 18857 composition records across product categories including Construction and building materials, Furniture and furnishings, Raw materials.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 · limited confidence.
Prevalence of SILICON DIOXIDE in our catalog (epa_cpdat).
Products
18,857
Brands
6
Typical roles
Catalog
Co-occurrence
Ingredients that frequently appear alongside SILICON DIOXIDE in the catalog.
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 18857 composition records across product categories including Construction and building materials, Furniture and furnishings, Raw materials. EPA CPDat classifies this chemical for functional uses including Abrasive, Viscosity modifier, Filler.
US
FDA
Route: BUCCAL; Dosage form: TABLET; Maximum daily exposure: 3 mg
US
FDA
Lingette Bebe 120x
Dalaa Baby
Route: DENTAL; Dosage form: GEL; Potency: 19 %w/w
US
FDA
Route: NASAL; Dosage form: GEL; Maximum daily exposure: 20 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 300 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED; Maximum daily exposure: 3 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Maximum daily exposure: 69 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED, EXTENDED RELEASE; Potency: NA
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 40 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 168 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, LIQUID FILLED; Maximum daily exposure: 106 mg
US
FDA
Route: ORAL; Dosage form: FILM, SOLUBLE; Maximum daily exposure: 2 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, DELAYED RELEASE; Potency: 3.2 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SOLUTION; Potency: 1.8 mg/120ml
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 200 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION, EXTENDED RELEASE; Potency: NA
US
FDA
Route: ORAL; Dosage form: LOZENGE; Maximum daily exposure: 120 mg
US
FDA
Route: ORAL; Dosage form: PELLET; Maximum daily exposure: 34 mg
US
FDA
Route: ORAL; Dosage form: POWDER; Maximum daily exposure: 602 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Maximum daily exposure: 280 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 2553 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 336 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 400 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 70 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 336 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 254 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE, EXTENDED RELEASE; Maximum daily exposure: 2 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Maximum daily exposure: 176 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 1190 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE PARTICLES; Maximum daily exposure: 170 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 450 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 166 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 336 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 220 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 68 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; Maximum daily exposure: 69 mg
US
FDA
Route: RECTAL; Dosage form: SUPPOSITORY; Potency: 14 mg
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: CAPSULE; Potency: NA
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: POWDER; Potency: NA
US
FDA
Route: SUBLINGUAL; Dosage form: TABLET; Maximum daily exposure: 10 mg
US
FDA
Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 6 mg
US
FDA
Route: TRANSDERMAL; Dosage form: FILM, EXTENDED RELEASE; Potency: 49 mg
US
FDA
Route: TRANSDERMAL; Dosage form: SYSTEM; Maximum daily exposure: 35 mg
US
FDA
Route: VAGINAL; Dosage form: CREAM; Maximum daily exposure: 51 mg
US
FDA
Route: VAGINAL; Dosage form: INSERT; Maximum daily exposure: 8 mg
US
FDA
FDA NDC lists this ingredient in 26 active drug products and 26 total products.
US
FDA
FDA NDC lists this ingredient in 521 active drug products and 570 total products.
US
FDA
openFDA substance registry classifies this ingredient as concept.
US
FDA
openFDA substance registry classifies this ingredient as chemical.